Fitzgerald, Julie C. http://orcid.org/0000-0001-9936-9569
Zane, Nicole R.
Himebauch, Adam S.
Reedy, Michael D.
Downes, Kevin J.
Topjian, Alexis A.
Furth, Susan L.
Thomas, Neal J.
Scheetz, Marc H.
Zuppa, Athena F.
Article History
First Online: 12 March 2019
Compliance with Ethical Standards
:
: This study was supported by the Division of Critical Care Medicine Russell Raphaely Endowed Chair of Critical Care Medicine at the Children’s Hospital of Philadelphia.
: Dr. Zane is supported by National Institutes of Health (NIH) Grant 2T32GM008562; Dr. Downes is supported by NIH Grant K23 HD091365, and he has received research support from Merck and Co. and Pfizer, Inc. unrelated to the current work; Dr. Topjian was previously supported by the NIH and Sage Therapeutics and currently receives support from Laerdal Medical; Dr. Furth is supported by NIH Grants U19 AR069525, U01 DK066174, P50 DK114786, and U01 HL125295; Dr. Scheetz was supported by NIH, National Institute of Allergy and Infectious Diseases Grant R15 AI105742, performs consulting for Achaogen, Paratek, and SIGA, and is a Grant Investigator for the CARE Foundation and Merck and Co.; and Dr. Zuppa is supported by the following NIH Grants: National Institute of Child Health and Human Development Grants UG1HD063108 and 1R21HD093369, National Institute of General Medical Sciences Grant R01GM094203, National Heart Lung and Blood Institute UG3HL141736; as well as Department of Defense Grant W81XWH-17-1-0668, and Zelda Therapeutics. JCF, ASH, MDR, and NJT have no conflicts of interest that are directly relevant to the content of this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.